KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Other Accumulated Expenses: 2009-2025

Historic Other Accumulated Expenses for Dynavax Technologies (DVAX) over the last 12 years, with Sep 2025 value amounting to $6.7 million.

  • Dynavax Technologies' Other Accumulated Expenses rose 50.94% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 50.94%. This contributed to the annual value of $4.3 million for FY2024, which is 4.65% down from last year.
  • Dynavax Technologies' Other Accumulated Expenses amounted to $6.7 million in Q3 2025, which was up 22.68% from $5.5 million recorded in Q2 2025.
  • Dynavax Technologies' 5-year Other Accumulated Expenses high stood at $6.7 million for Q3 2025, and its period low was $3.4 million during Q1 2021.
  • Over the past 3 years, Dynavax Technologies' median Other Accumulated Expenses value was $4.6 million (recorded in 2024), while the average stood at $4.9 million.
  • Per our database at Business Quant, Dynavax Technologies' Other Accumulated Expenses crashed by 55.53% in 2021 and then spiked by 89.48% in 2022.
  • Quarterly analysis of 5 years shows Dynavax Technologies' Other Accumulated Expenses stood at $4.7 million in 2021, then climbed by 1.86% to $4.8 million in 2022, then dropped by 5.34% to $4.5 million in 2023, then decreased by 4.65% to $4.3 million in 2024, then skyrocketed by 50.94% to $6.7 million in 2025.
  • Its Other Accumulated Expenses was $6.7 million in Q3 2025, compared to $5.5 million in Q2 2025 and $5.7 million in Q1 2025.